Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
81.3 USD | -2.03% | -2.50% | +4.67% |
May. 22 | Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target | MT |
May. 16 | Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.67% | 13.08B | |
+62.47% | 62.59B | |
-2.29% | 41.18B | |
+44.02% | 40.29B | |
-8.29% | 27.9B | |
+11.60% | 26.21B | |
-22.05% | 19.09B | |
+25.11% | 12.26B | |
+28.03% | 12.05B | |
-8.24% | 11.28B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating